Fluralaner (Bravecto ® ) treatment kills Aedes aegypti after feeding on Dirofilaria immitis-infected dogs.
Autor: | Duncan K; Merck Animal Health, Rahway, NJ, USA. kathryn.duncan@merck.com.; College of Veterinary Medicine, Oklahoma State University, Stillwater, OK, USA. kathryn.duncan@merck.com., Barrett AW; Merck Animal Health, Rahway, NJ, USA., Little SE; College of Veterinary Medicine, Oklahoma State University, Stillwater, OK, USA., Sundstrom KD; College of Veterinary Medicine, Oklahoma State University, Stillwater, OK, USA., Guerino F; Merck Animal Health, Rahway, NJ, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Parasites & vectors [Parasit Vectors] 2023 Jun 20; Vol. 16 (1), pp. 208. Date of Electronic Publication: 2023 Jun 20. |
DOI: | 10.1186/s13071-023-05819-9 |
Abstrakt: | Background: Transmission of canine heartworm (Dirofilaria immitis) from infected to naïve dogs is dependent on successful mosquito feeding and survival. Methods: To determine whether treating heartworm-infected dogs with fluralaner (Bravecto ® ) limits the survival of infected mosquitoes, and potentially the transmission of D. immitis, we allowed female mosquitoes to feed on microfilaremic dogs and evaluated mosquito survival and infection with D. immitis. Eight dogs were experimentally infected with D. immitis. On day 0 (~ 11 months post-infection), four microfilaremic dogs were treated with fluralaner according to label directions while the other four were non-treated controls. Mosquitoes (Aedes aegypti Liverpool) were allowed to feed on each dog on days -7, 2, 30, 56, and 84. Fed mosquitoes were collected, and the number of live mosquitoes determined at 6 h, 24 h, 48 h, and 72 h post-feeding. Surviving mosquitoes held for 2 weeks were dissected to confirm third-stage D. immitis larvae; PCR (12S rRNA gene) was performed post-dissection to identify D. immitis in mosquitoes. Results: Prior to treatment, 98.4%, 85.1%, 60.7%, and 40.3% of mosquitoes fed on microfilaremic dogs were alive at 6 h, 24 h, 48 h, and 72 h post-feeding, respectively. Similarly, mosquitoes fed on microfilaremic, non-treated dogs were alive 6 h post-feeding (98.5-100%) throughout the study. In contrast, mosquitoes fed on fluralaner-treated dogs 2 days after treatment were dead or severely moribund by 6 h post-feeding. At 30 and 56 days post-treatment, > 99% of mosquitoes fed on treated dogs were dead by 24 h. At 84 days post-treatment, 98.4% of mosquitoes fed on treated dogs were dead by 24 h. Before treatment, third-stage larvae of D. immitis were recovered from 15.5% of Ae. aegypti 2 weeks after feeding, and 72.4% were positive for D. immitis by PCR. Similarly, 17.7% of mosquitoes fed on non-treated dogs had D. immitis third-stage larvae 2 weeks after feeding, and 88.2% were positive by PCR. Five mosquitoes fed on fluralaner-treated dogs survived 2 weeks post-feeding, and 4/5 were from day 84. None had third-stage larvae at dissection, and all were PCR-negative. Conclusion: The data indicate that fluralaner treatment of dogs kills mosquitoes and thus would be expected to reduce transmission of heartworm in the surrounding community. (© 2023. Merck & Co., Inc., Rahway, NJ, USA and its affiliates.) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |